Epitalon Reverses Immune and Clotting Issues in Pituitary-Deficient and Aging Chickens

The pituitary gland plays a crucial role in regulating numerous bodily functions, including the immune system and hemostasis (the process of blood clotting and clot breakdown). Dysfunction or removal of this gland, as well as natural aging, can lead to significant disturbances in these vital systems, manifesting as impaired immunity and an increased risk of abnormal blood clotting. This study investigated whether the peptide Epitalon could mitigate these immune and hemostatic dysregulations induced by either pituitary removal or advanced age in chickens.

The administration of Epitalon significantly ameliorated the physiological disturbances observed in both models. In the neonatally hypophysectomized chicken, Epitalon largely eliminated the cellular and humoral immunity disturbances, as well as the pronounced hypercoagulation (excessive blood clotting) and fibrinolysis depression (impaired clot breakdown) that developed within 1.5 months. Similar, though less pronounced, beneficial effects were observed in the old hens. Epitalon effectively reversed the severe immune and hemostatic dysfunctions caused by pituitary removal and aging, demonstrating a broad restorative capacity. The therapeutic effect of Epitalon was notably stronger in the young, pituitary-deficient chickens compared to the older hens, suggesting a potential difference in responsiveness based on the underlying cause or duration of dysfunction. This indicates a substantial improvement in key physiological markers in the treated groups compared to untreated controls, although specific quantitative data like percentages or p-values were not provided in the abstract.